Probi
Probi AB is a Sweden-based company specializing in the research, development, manufacturing, and distribution of probiotics. The company operates in two primary business areas: Functional Foods, which focuses on integrating probiotics into food products in collaboration with various food companies, and Consumer Healthcare, which develops and sells probiotics in partnership with pharmaceutical companies and self-care product manufacturers. Probi's research emphasizes the health benefits of probiotics in areas such as gut health, immune function, nutrient absorption, and stress recovery. The company's product portfolio includes notable brands like Probi Digestis and Probi Defendum. Probi collaborates with several well-known partners, including Danone and Kraft Foods, to deliver effective probiotic solutions across multiple regions, including the United States, Europe, and Asia-Pacific.
Nutraceutix is a specialty pharmaceutical company that develops and commercializes a range of prescription, over-the-counter, and nutritional products. Utilizing a controlled delivery technology platform, Nutraceutix produces both water-soluble and insoluble drugs, offering formulations in various doses. Its product portfolio encompasses analgesics, cardiovascular medications, diabetes treatments, anti-nausea drugs, and dietary supplements, including combinations of glucosamine and chondroitin, calcium, and other dietary components. Among its lead drug candidates is a 12-hour extended-release formulation of ibuprofen, designed to address pain, fever, and inflammation, which has successfully completed Phase III clinical trials. Additionally, the company is advancing a 12-hour formulation of pseudoephedrine, aimed at alleviating sinus pressure associated with allergies and the common cold. Nutraceutix is headquartered in Redmond, Washington, and operates as a subsidiary of Probi USA, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.